CIK: 1388406 - Address: C/O Kymera Therapeutics, Inc., 500 North Beacon Street, 4Th Floor, Watertown, MA 02472
9 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg
S%ret11161141-63-66-11-14
S%wins00010010010050

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
3/25/26 17:15
3/23/26
KYMRKymera Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagChadwick Jeremy GMAOCOOM.dm3,23529.64010961D
3/25/26 17:15
3/23/26
KYMRKymera Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagChadwick Jeremy GMAOCOOS.dm-9,04878.020-116-6561D
3/11/26 18:51
3/11/26
KYMRKymera Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagChadwick Jeremy GMAOCOOM.d87043.500204268D
3/11/26 18:51
3/11/26
KYMRKymera Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagChadwick Jeremy GMAOCOOS.d-2,14683.300-26-2768D
3/4/26 18:00
3/2/26
KYMRKymera Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagChadwick Jeremy GMAOCOOS.dm-51686.540-6-774D
5/23/25 16:30
5/23/25
KYMRKymera Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagChadwick Jeremy GMAOCOOS-7529.300-3-466D
3/3/25 18:30
3/3/25
KYMRKymera Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagChadwick Jeremy GMAOCOOS.d-4230.450-1-268D
5/23/24 16:10
5/23/24
KYMRKymera Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagChadwick Jeremy GMAOCOOS-9034.990-3-644D
1/6/09 16:30
1/5/09
SNTASynta Pharmaceuticals CorpHealthDrugPharmaceutical PreparationsChadwick Jeremy GMAOSVP,Pgm S-286.201-5-221661141-63-66-11

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact